Shinpei Kawaoka

Dr. Shinpei Kawaoka

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
HHHiroaki Hojo
Hiroaki Hojo
SESora Enya
Sora Enya
MAMiki Arai
Miki Arai
YSYutaka Suzuki
Yutaka Suzuki
TNTakashi Nojiri
Takashi Nojiri
SKShinpei Kawaoka
Shinpei Kawaoka
Remote reprogramming of hepatic circadian transcriptome by breast cancer

16 May 2013 in RNA
Verified
Journal Article
Open access
PDF file
NINatsuko Izumi
Natsuko Izumi
SKShinpei Kawaoka
Shinpei Kawaoka
SYSatoshi Yasuhara
Satoshi Yasuhara
YSYutaka Suzuki
Yutaka Suzuki
SSSumio Sugano
Sumio Sugano
YTYukihide Tomari
Yukihide Tomari
PIWI-interacting RNAs (piRNAs) defend the genome against transposon activity in animal gonads. The Hsp90 chaperone machinery has been implicated in the piRNA pathway, but its exact role remains obscure. Here, we examined the effect of 17-N-allylamino-17-demethoxygeldanamycin (17-AAG), an Hsp90-specific inhibitor, on the piRNA pathway. In the silkworm ovary-derived BmN4 cells, 17-AAG treatment reduced the level of piRNAs and PIWI proteins. In vitro, the 5′-nucleotide preference upon precursor piRNA loading was compromised by 17-AAG, whereas 3′-end trimming and 2′-O-methylation were unaffected. Our data highlight a role of Hsp90 in accurate loading of precursor piRNAs into PIWI proteins.

19 December 2012 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
SKShinpei Kawaoka
Shinpei Kawaoka
KHKahori Hara
Kahori Hara
KSKeisuke Shoji
Keisuke Shoji
MKMaki Kobayashi
Maki Kobayashi
Toru ShimadaToru Shimada
Toru Shimada
SKSusumu Katsuma
Susumu Katsuma
PIWI-interacting RNA (piRNA) clusters act as anti-transposon/retrovirus centers. Integration of selfish jumping elements into piRNA clusters generates de novo piRNAs, which in turn exert trans-silencing activity against these elements in animal gonads. To date, neither genome-wide chromatin modification states of piRNA clusters nor a mode for piRNA precursor transcription have been well understood. Here, to understand the chromatin landscape of piRNA clusters and how piRNA precursors are generated, we analyzed the transcriptome, transcription start sites (TSSs) and the chromatin landscape of the BmN4 cell line, which harbors the germ-line piRNA pathway. Notably, our epigenomic map demonstrated the highly euchromatic nature of unique piRNA clusters. RNA polymerase II was enriched for TSSs that transcribe piRNA precursors. piRNA precursors possessed 5′-cap structures as well as 3′-poly A-tails. Collectively, we envision that the euchromatic, opened nature of unique piRNA clusters or piRNA cluster-associated TSSs allows piRNA clusters to capture new insertions efficiently.

5 July 2024 in Science
Verified
Journal Article
Closed access
AOAkiko Oguchi
Akiko Oguchi
ASAkari Suzuki
Akari Suzuki
SKShuichiro Komatsu
Shuichiro Komatsu
HYHiroyuki Yoshitomi
Hiroyuki Yoshitomi
SBShruti Bhagat
Shruti Bhagat
SYSoichiro Yoshino
Soichiro Yoshino
Transcribed enhancer maps can reveal nuclear interactions underpinning each cell type and connect specific cell types to diseases. Using a 5′ single-cell RNA sequencing approach, we defined transcription start sites of enhancer RNAs and other classes of coding and noncoding RNAs in human CD4 + T cells, revealing cellular heterogeneity and differentiation trajectories. Integration of these datasets with single-cell chromatin profiles showed that active enhancers with bidirectional RNA transcription are highly cell type–specific and that disease heritability is strongly enriched in these enhancers. The resulting cell type–resolved multimodal atlas of bidirectionally transcribed enhancers, which we linked with promoters using fine-scale chromatin contact maps, enabled us to systematically interpret genetic variants associated with a range of immune-mediated diseases.

13 June 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
MHMiki Arai Hojo
Miki Arai Hojo
KMKyoko Masuda
Kyoko Masuda
HHHiroaki Hojo
Hiroaki Hojo
YNYosuke Nagahata
Yosuke Nagahata
KYKeiko Yasuda
Keiko Yasuda
SKShinpei Kawaoka
Shinpei Kawaoka
During thymic negative selection, autoreactive thymocytes carrying T cell receptor (TCR) with overtly strong affinity to self-MHC/self-peptide are removed by Bim-dependent apoptosis, but how Bim is specifically regulated to link TCR activation and apoptosis induction is unclear. Here we identify a murine T cell-specific genomic enhancer EBAB (Bub1-Acoxl-Bim), whose deletion leads to accumulation of thymocytes expressing high affinity TCRs. Consistently, EBAB knockout mice have defective negative selection and fail to delete autoreactive thymocytes in various settings, with this defect accompanied by reduced Bim expression and apoptosis induction. By contrast, EBAB is dispensable for maintaining peripheral T cell homeostasis via Bim-dependent pathways. Our data thus implicate EBAB as an important, developmental stage-specific regulator of Bim expression and apoptosis induction to enforce thymic negative selection and suppress autoimmunity. Our study unravels a part of genomic enhancer codes that underlie complex and context-dependent gene regulation in TCR signaling.

15 June 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
RMRin Mizuno
Rin Mizuno
HHHiroaki Hojo
Hiroaki Hojo
MTMasatomo Takahashi
Masatomo Takahashi
SKSoshiro Kashio
Soshiro Kashio
SESora Enya
Sora Enya
SKShinpei Kawaoka
Shinpei Kawaoka
Cancers disrupt host homeostasis in various manners but the identity of host factors underlying such disruption remains largely unknown. Here we show that nicotinamide-N-methyltransferase (NNMT) is a host factor that mediates metabolic dysfunction in the livers of cancer-bearing mice. Multiple solid cancers distantly increase expression of Nnmt and its product 1-methylnicotinamide (MNAM) in the liver. Multi-omics analyses reveal suppression of the urea cycle accompanied by accumulation of amino acids, and enhancement of uracil biogenesis in the livers of cancer-bearing mice. Importantly, genetic deletion of Nnmt leads to alleviation of these metabolic abnormalities, and buffers cancer-dependent weight loss and reduction of the voluntary wheel-running activity. Our data also demonstrate that MNAM is capable of affecting urea cycle metabolites in the liver. These results suggest that cancers up-regulate the hepatic NNMT pathway to rewire liver metabolism towards uracil biogenesis rather than nitrogen disposal via the urea cycle, thereby disrupting host homeostasis.